Asthma - FDA calls for stronger warnings on asthma drugs

FDA calls for stronger warnings on asthma drugs
Reuters.uk, UK - Nov 18, 2005 LOS ANGELES (Reuters) - Regulators on Friday asked the makers of three popular asthma medications to add new warnings to their labels stating that the drugs

Breathless in slums: Asthma on the rise
Pune Newsline, India - Nov 22, 2005 studies on respiratory health. India has never been considered a country with high prevalence of asthma. But this study shows

Bid for 5m asthma unit at Perth
Evening Telegraph, UK - Nov 24, 2005 The unit will concentrate on research into childhood asthma. NHS Tayside today gave the go-ahead for the university to develop two vacant wards at PRI.

Child asthma hospitalizations drop
Seattle Post Intelligencer - Nov 18, 2005 "When I first got here, I didn't know anything about asthma," said Luu, through an interpreter. "It just hurt me to see him like that.".

Fetal growth retarded more by severe asthma than smoking
AustralianDoctor.com (subscription), Australia - Nov 15, 2005 by Jane McCredie. SEVERE exacerbations of asthma in pregnancy have a greater impact on birth weight than smoking in pregnancy, an Australian study shows.

Asthma Patients Do Better Under Allergists' Care
Daily News Central, NV - Nov 18, 2005 Asthma patients treated by an allergist reported fewer problems and better quality of life than those who received treatment from primary-care physicians.

Warnings for Asthma Drugs Sought
Washington Post, United States - Nov 18, 2005 US regulators yesterday asked the makers of three popular asthma medications to add warnings to their labels stating that the drugs could increase the chances

Glaxo hit by US ruling on its top-selling asthma drug
Scotsman, United Kingdom - Nov 21, 2005 SHARES in GlaxoSmithKline fell 5 per cent yesterday after the US Food and Drug and Administration proposed restrictions on its top-selling asthma drug, Advair

GlaxoSmithKline opposes US asthma drug proposals
Reuters - Nov 18, 2005 drugmaker GlaxoSmithKline (GSK.L: Quote, Profile, Research) said on Friday it disagreed with the changes to the labelling of two of its asthma drugs proposed